EGFR and hepatocellular carcinoma: These results were similar to those reported in previous studies [6,7,8], showing that the overexpression of EGFR activated the Akt and ERK signaling pathway to increase HCC cell survival and proliferation, which, in turn, induced sorafenib resistance.